Captor Therapeutics Spolka Akcyjna (WSE:CTX)

WSE:CTX Ratios and Metrics

Market cap in millions PLN. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May 27, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	496	398	197	460	667	742
Market Cap Growth	156.91%	101.82%	-57.12%	-31.04%	-10.15%	-
Enterprise Value	488	366	154	410	583	-
Last Close Price	78.00	72.00	42.30	99.00	160.00	179.80
Forward PE	24.78	166.47	-	-	-	-
PS Ratio	106.34	85.42	12.46	34.84	72.82	186.20
PB Ratio	21.10	16.95	3.06	6.64	6.92	5.98
P/TBV Ratio	22.22	17.85	3.08	6.67	6.97	5.99
EV/Sales Ratio	104.81	78.52	9.73	31.04	63.61	-
Debt / Equity Ratio	0.15	0.15	0.09	0.06	0.07	0.07
Net Debt / Equity Ratio	-0.30	-0.30	-0.52	-1.04	-0.87	-0.88
Net Debt / EBITDA Ratio	0.18	0.18	0.99	1.06	2.68	4.31
Net Debt / FCF Ratio	0.19	0.19	1.04	1.30	3.52	3.27
Asset Turnover	0.07	0.07	0.17	0.13	0.07	0.05
Quick Ratio	0.80	0.80	3.87	3.30	7.51	7.92
Current Ratio	2.27	2.27	3.90	3.32	7.57	7.98
Return on Equity (ROE)	-95.50%	-95.50%	-57.48%	-85.28%	-32.55%	-52.88%
Return on Assets (ROA)	-42.77%	-42.77%	-26.36%	-43.40%	-18.69%	-24.24%
Return on Capital Employed (ROCE)	-173.80%	-173.80%	-57.80%	-103.50%	-38.50%	-25.80%
Earnings Yield	-8.47%	-10.55%	-19.48%	-15.35%	-5.38%	-4.39%
FCF Yield	-7.57%	-9.43%	-16.38%	-12.00%	-3.57%	-4.52%
Buyback Yield / Dilution	-18.42%	-18.42%	-0.30%	-11.46%	-0.97%	-14.99%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.